We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
-25.08%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$463M
AUM Growth
-$122M
(-21%)
Cap. Flow
+$51.3M
Cap. Flow
% of AUM
11.09%
Top 10 Holdings %
Top 10 Hldgs %
9.68%
Holding
1,051
New
472
Increased
169
Reduced
110
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$13.6M |
| 2 |
Occidental Petroleum
OXY
|
+$6.95M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$6.41M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$4.25M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.5M |
| 2 |
Verizon
VZ
|
+$6.68M |
| 3 |
Target
TGT
|
+$6.64M |
| 4 |
Roku
ROKU
|
+$6.35M |
| 5 |
Walmart Inc
WMT
|
+$5.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.02% |
| 2 | Healthcare | 14.77% |
| 3 | Consumer Discretionary | 13.92% |
| 4 | Industrials | 9.71% |
| 5 | Consumer Staples | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teva Pharmaceuticals
TEVA
$43.8B
| $1.36M | 0.29% |
+151,200
| New | +$1.55M |
|
77
ResMed
RMD
$34B
| $1.35M | 0.29% |
9,198
-16,400
| -64% | -$2.61M |
|
|
NVRO
78
DELISTED
NEVRO CORP.
NVRO
| $1.33M | 0.29% |
13,267
+1,726
| +15% | +$208K |
|
79
Chubb
CB
$131B
| $1.31M | 0.28% |
11,729
+8,214
| +234% | +$1.18M |
|
|
FTCH
80
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.31M | 0.28% |
+165,804
| New | +$1.79M |
|
|
DOCU
81
DocuSign
DOCU
$12.2B
| $1.29M | 0.28% |
14,000
-33,900
| -71% | -$2.73M |
|
82
Qualcomm
QCOM
$176B
| $1.29M | 0.28% |
+19,100
| New | +$1.57M |
|
83
Royal Caribbean
RCL
$76.2B
| $1.28M | 0.28% |
+39,903
| New | +$3.65M |
|
84
General Motors
GM
$75.6B
| $1.26M | 0.27% |
60,577
+43,177
| +248% | +$1.32M |
|
|
DISH
85
DELISTED
DISH Network Corp.
DISH
| $1.25M | 0.27% |
62,500
+41,323
| +195% | +$1.34M |
|
86
Jack Henry & Associates
JKHY
$12.1B
| $1.24M | 0.27% |
+7,994
| New | +$1.24M |
|
87
Ciena
CIEN
$56.6B
| $1.23M | 0.27% |
30,953
-7,700
| -20% | -$316K |
|
88
Middleby
MIDD
$5.14B
| $1.22M | 0.26% |
+21,400
| New | +$2.1M |
|
89
Acuity Brands
AYI
$10.2B
| $1.21M | 0.26% |
+14,099
| New | +$1.55M |
|
90
Chegg
CHGG
$89M
| $1.21M | 0.26% |
33,700
-600
| -2% | -$23.4K |
|
91
EOG Resources
EOG
$75.8B
| $1.2M | 0.26% |
+33,400
| New | +$2.17M |
|
92
Keysight
KEYS
$55.5B
| $1.18M | 0.26% |
14,100
+3,300
| +31% | +$313K |
|
|
LSI
93
DELISTED
Life Storage, Inc.
LSI
| $1.18M | 0.25% |
18,677
+2,721
| +17% | +$194K |
|
94
Mattel
MAT
$4.26B
| $1.18M | 0.25% |
133,484
+95,784
| +254% | +$1.17M |
|
95
Zimmer Biomet
ZBH
$19B
| $1.16M | 0.25% |
11,845
-6,489
| -35% | -$851K |
|
96
Xerox
XRX
$390M
| $1.16M | 0.25% |
61,300
+29,300
| +92% | +$931K |
|
97
W.R. Berkley
WRB
$25.4B
| $1.15M | 0.25% |
49,725
+5,647
| +13% | +$168K |
|
98
Procter & Gamble
PG
$333B
| $1.14M | 0.25% |
10,400
-39,900
| -79% | -$4.79M |
|
99
American Airlines Group
AAL
$9.08B
| $1.14M | 0.25% |
+93,582
| New | +$2.13M |
|
100
Wabtec
WAB
$50.2B
| $1.13M | 0.25% |
23,564
+20,100
| +580% | +$1.38M |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Bayesian Capital Management held 1,051 positions worth $463M, down 21% from $585M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Bayesian Capital Management deployed $51.3M of net new capital in Q1 2020, opening 472 new positions and adding to 169 existing holdings. Its largest new stake was Occidental Petroleum: 211,482 shares worth $2.45M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Target, an estimated $6.64M trimmed.
- Bayesian Capital Management's largest Q1 2020 buy was Occidental Petroleum: 211,482 shares worth $2.45M.
- Bayesian Capital Management added most to Walgreens Boots Alliance in Q1 2020, an estimated $13.6M increase.
- Bayesian Capital Management's biggest Q1 2020 reduction was Target, cutting an estimated $6.64M.
- Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2020, selling an estimated $35.5M.
- Bayesian Capital Management's ten largest holdings make up 9.7% of its $463M portfolio in Q1 2020.
- Bayesian Capital Management opened 472 new positions and closed 299 in Q1 2020.
- Bayesian Capital Management's portfolio value fell 21% quarter-over-quarter to $463M.
Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.